No Data
Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the
① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.
LBX Pharmacy Chain Joint Stock Company's (SHSE:603883) Market Cap Dropped CN¥699m Last Week; Retail Investors Bore the Brunt
Consumer confidence in the USA has seen its largest decline in nearly four years, causing both the stock market and Bonds yields to suffer.
The concerns of USA consumers about the overall economic outlook have led to the largest decline in confidence since August 2021, further indicating that the uncertainty of the Trump administration's policies has put pressure on LBX Pharmacy Chain Joint Stock. Data released by the World Business Council on Tuesday showed that the confidence Index fell by 7 points to 98.3, marking a decline for the third consecutive month. This figure is lower than the predictions made by all economists surveyed by Bloomberg. Following the data release, the USA stock market and bonds yields both declined. The indicator measuring expectations for the next six months recorded its largest decline in three and a half years; however, the decline in the current situation index was more moderate. Different age groups and all.
LBX Pharmacy Chain Joint Stock (603883.SH): is closely monitoring the applications of Smart Healthcare and AI in retail pharmacies and Internet Hospitals.
On February 25, Gelonghui reported that LBX Pharmacy Chain Joint Stock (603883.SH) stated on its investor interaction platform that the company is closely monitoring the relevant applications of Smart Healthcare and AI in retail pharmacies and Internet Hospitals. In the future, the company will continue to deepen its efforts in digital intelligence, and explore the integration and application of AI technology in supply chain management, compliance operations, pharmaceutical services, and cost reduction and efficiency improvement. The company aims to continuously use AI technology as a technological hard strength in its strategic practice of building a 'technology-driven health service platform', achieving dual improvements in Consumer satisfaction and corporate benefits.
Does LBX Pharmacy Chain (SHSE:603883) Have A Healthy Balance Sheet?
Dialogue with Jiang Xipei: Companies going overseas need to promote the global flow of talent, capital, and technology.
The "Praise for China's Economy - Entrepreneur's Night" was held on January 15 in Peking. Sina Finance interviewed Jiang Xipei, the founder and Chairman of the Board of Far East Holding Group Co., Ltd., regarding how to expand domestic demand and promote Consumer-related Topics in the current domestic context. He stated, "We need to base ourselves domestically and embrace the Global market, winning competition through better products and services to better serve society and develop further." He mentioned that, although the current situation is significantly better than before the reform and opening up, people's longing for a better life has never ceased, especially regarding infrastructure and improvements in living standards in various countries.
Insufficient Growth At LBX Pharmacy Chain Joint Stock Company (SHSE:603883) Hampers Share Price
